HIGHLIGHTS
- who: A Redox-active Mn Porphyrin and colleagues from the Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, USA have published the research work: A Redox-active Mn Porphyrin, MnTnBuOE-2-PyP Synergizes with Carboplatin in Treatment of Chemoresistant Ovarian Cell Line, in the Journal: Oxidative Medicine and Cellular Longevity of 11/Nov/2021
- what: The authors compare the level of mitochondrial OXPHOS and glycolysis between OVCD with its parental cell OV90 by measuring OCR and ECAR, respectively. Since MnP had anticancer effect on OV90 and OVCD, the authors compare the efficacy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.